Literature DB >> 23042306

Safety of endoscopic procedures after acute myocardial infarction: a systematic review.

Marek Cena1, Javier Gomez, Tareq Alyousef, Richard G Trohman, Krzysztof Pierko, Rajender Agarwal.   

Abstract

BACKGROUND: The management of patients who develop gastrointestinal (GI) bleeding after acute myocardial infarction (MI) is difficult due to concerns about possible cardiovascular complications. Gastroenterologists are often reluctant to perform endoscopic procedures despite urgent indications. We performed a systematic review of the literature to determine the safety of endoscopic procedures after MI.
METHODS: We searched MEDLINE, EMBASE and the Cochrane Central Register of Controlled trials for controlled clinical trials or case series examining the diagnostic efficacy and complications of esophagogastroduodenoscopy (EGD), colonoscopy and flexible sigmoidoscopy after MI. Title and abstract screening was followed by full-text review with subsequent data extraction of included studies.
RESULTS: A total of seven studies met inclusion criteria. Four studies evaluated safety and efficacy of EGD after MI. The reported complication rate ranged between 1-8%, with a large predominance of minor complications. We found one study addressing safety of flexible sigmoidoscopy that reported minor complications in two patients. We also identified one study addressing the safety of colonoscopy after MI, which showed a complication rate of 9%. Most of these complications were minor. A decision analysis was also included in this review.
CONCLUSIONS: Our review demonstrated that endoscopic procedures are safe and beneficial in stable patients with GI bleeding after recent MI and should be performed without a requisite delay. Unstable patients should undergo endoscopic procedures only in the intensive care setting, after stabilization and with close monitoring.

Entities:  

Mesh:

Year:  2012        PMID: 23042306     DOI: 10.5603/cj.2012.0083

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  6 in total

1.  The Impact of Cardiac Dysfunction Based on Killip Classification on Gastrointestinal Bleeding in Acute Myocardial Infarction.

Authors:  Yu Liu; De-Jing Feng; Le-Feng Wang; Li-Hong Liu; Zheng-Hong Ren; Jian-Yu Hao; Kui-Bao Li; Mu-Lei Chen
Journal:  Front Med (Lausanne)       Date:  2022-06-23

2.  The Clinical Dilemma of Esophagogastroduodenoscopy for Gastrointestinal Bleeding in Cardiovascular Disease Patients: A Nationwide-Based Retrospective Study.

Authors:  Chao-Feng Chang; Wu-Chien Chien; Chi-Hsiang Chung; Hsuan-Hwai Lin; Tien-Yu Huang; Peng-Jen Chen; Wei-Kuo Chang; Hsin-Hung Huang
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

3.  Risk factors of in-hospital mortality among patients with upper gastrointestinal bleeding and acute myocardial infarction.

Authors:  Lingjie He; Jianwei Zhang; Shutian Zhang
Journal:  Saudi J Gastroenterol       Date:  2018 May-Jun       Impact factor: 2.485

4.  Safety of gastrointestinal endoscopy in patients with acute coronary syndrome and concomitant gastrointestinal bleeding.

Authors:  Ahmed A Elkafrawy; Mohamed Ahmed; Mohammad Alomari; Ahmed Elkaryoni; Kevin F Kennedy; Wendell K Clarkston; Donald R Campbell
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

5.  Randomized controlled trial of early endoscopy for upper gastrointestinal bleeding in acute coronary syndrome patients.

Authors:  Chen-Shuan Chung; Chieh-Chang Chen; Kuan-Chih Chen; Yu-Jen Fang; Wen-Feng Hsu; Yen-Nien Chen; Wei-Chuang Tseng; Cheng-Kuan Lin; Tzong-Hsi Lee; Hsiu-Po Wang; Yen-Wen Wu
Journal:  Sci Rep       Date:  2022-04-06       Impact factor: 4.379

6.  Clinical Characteristics and Risk Factors of In-Hospital Mortality in Patients With Acute Myocardial Infarction With Subsequent Gastrointestinal Bleeding: A Single-Center Experience.

Authors:  Xin Su; Yuzhen Wei; Shuo Pang; Zeqing Zhang; Yunxiao Zhang; Peipei Zheng; Haiyu Li; Haiqiang Sang; Jianzeng Dong
Journal:  Front Cardiovasc Med       Date:  2022-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.